Cambridge Investment Research Advisors »

Corcept Therapeutics Incorporated shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 27k 46.29
2024-06-30 $9.3M 286k 32.49
2024-03-31 $8.2M 324k 25.19
2023-12-31 $348k 11k 32.44
2023-09-30 $4.7M 174k 27.25
2023-03-31 $7.9M 366k 21.66

More positions owned by Cambridge Investment Research Advisors

Apple Inc Com (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Index Fds Value Etf (VTV)

View all positions for Cambridge Investment Research Advisors

Top funds holding Corcept Therapeutics Incorporated

BlackRock
BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Btim
First Trust Advisors
Morgan Stanley
Jacobs Levy Equity Management

View all funds holding Corcept Therapeutics Incorporated